cleistanthin B

10/01/2016 - "None of the three doses of cleistanthin B was effective against the solid tumor. "
10/01/2016 - "But cleistanthin B in the doses used is not effective against solid tumor."
10/01/2016 - "Only cleistanthin B 50 mg/kg significantly reduced the elevated WBC counts in EAC tumor bearing animals. "
10/01/2016 - "Cleistanthin B has antitumor activity against EAC and DAL tumor mice but it is not as effective as 5-FU. "
10/01/2016 - "Both 5-FU and cleistanthin B 50 mg/kg reversed the malignancy induced increase in neutrophils and platelet counts and decrease in lymphocyte counts but not to the normal range. "

12/01/1998 - "Cervical carcinoma (SiHa) cells exposed to cleistanthin B shrank, rounded up and had condensed chromatin and fragmented nuclei. "
10/01/2016 - "To evaluate the in vivo antitumor activity of cleistanthin B in Ehrlich's ascites carcinoma (EAC) and Dalton's ascites lymphoma (DAL) cell lines induced malignant ascites mouse models and DAL cell line induced solid tumor mouse model. "

01/01/2014 - "In addition, cleistanthin B caused spotty necrosis of liver in higher doses. "

10/01/2016 - "To evaluate the in vivo antitumor activity of cleistanthin B in Ehrlich's ascites carcinoma (EAC) and Dalton's ascites lymphoma (DAL) cell lines induced malignant ascites mouse models and DAL cell line induced solid tumor mouse model. "

12/01/1998 - "We have previously shown that cleistanthin B is clastogenic and induces micronuclei formation and chromosomal aberrations. "